Cesarean Section Clinical Trial
— NOCEPAINOfficial title:
Interest of Tecartherapy on a Painful Caesarean Section Scar: a Randomized Clinical Trial.
Cesareans are a frequent procedure in obstetrics and 15.4% (95% CI, 9.9-20.9%) of women with cesareans still have pain at 3 months after delivery. Currently, self-massage of the scar is recommended to them. Post-cesarean pain is associated with psychological disorders (including, e.g., anxiety, depression). Tecar therapy could improve the healing and pain associated with cesareans and therefore improve women's quality of life and their satisfaction. Objectives: The principal objective is to study the analgesic efficacy of tecar therapy for postoperative scar pain and/or discomfort at 3 month after cesarean delivery, by comparing it with sham tecar therapy. A randomized clinical trial with 2 parallel arms and single blinding, to study the efficacy of this medical device for therapeutic purposes. In both groups (randomization stratified as a first cesarean or repeat cesarean), the women will have the standard recommended treatment - manual self-massage of the scar. Women's instruction in this self-massage will be structured and identical for both groups, including the provision of an informational document describing how to perform this massage. The training will be provided immediately after randomization. - Description of the experimental group These women will receive Tecar through Winback® technology [CE medical 1984, Norma 60601-2, ISO9001, ISO13485. Class IIa medical device, CET (capacitative mode) 400 VA and RET (resistant mode) 100 Watts, weight 4 Kg)]. Each session will last for 20 minutes, and each individual will have 3 sessions over a period of 3 weeks. - Description of the control group ("sham treatment") The women will follow the same study design as the experimental group with activation of the portable placebo device identical to the active medical. Each session will last for 20 minutes, and each individual will have 3 sessions over a 3-week period. Principal endpoint: Visual analogic scale (VAS) for pain and/or discomfort at 3 months after delivery partum (with a ruler scored from 0 for no pain to 10 for the worst pain imaginable). Succinct description of the products: "Tecar" is an acronym for a type of therapy (transfer electrical capacitive and resistive). The Winback® is a portable, easy-to-handle noninvasive regenerator. This study will use only the instrumental mode and 4-cm electrodes. During each session, this electrode will be moved over the entire scar. We will use the following 3 modes: capacitive (CET), CET Dynamic, and resistant (RET). These allow us to standardize the treatment without taking into account either the thickness of the abdominal wall or the woman's morphology. Each session will take 20 minutes (CET for 4 min, CET Dynamic 6 min, RET 6 min and CET 4 min). The intensity of CET and RET will be adapted to each woman and the diathermy chosen according to the woman's threshold of comfort, to be determined by her at each session, in the experimental group. There will be 1 session a week for 3 weeks. Study plan and procedures: The eligible women will be identified by the physicians in both of the obstetrics departments participating in this study. The women will receive oral information as well as written information. If they are interested, they will be offered an inclusion visit, normally scheduled for one week later. After a second verification of the eligibility criteria at this inclusion meeting, reading the information form and signing the consent, they will be randomized into one of the two groups by random drawing. Each woman will have 3 sessions (1 session a week for 20 min for 3 consecutive weeks): active treatment by tecar therapy or sham/placebo tecar therapy. They will receive self-administered questionnaires at 3 and 6 months after delivery to be completed and returned.
Status | Recruiting |
Enrollment | 120 |
Est. completion date | July 2025 |
Est. primary completion date | July 2025 |
Accepts healthy volunteers | No |
Gender | Female |
Age group | 18 Years to 50 Years |
Eligibility | Inclusion Criteria: - Adult woman(=18 years and =50 years), with a painful cesarean scar (VAS = 4), at the 6-8 weeks postpartum visit (reimbursed by the French national health insurance fund), regardless of whether or not she is breastfeeding, - Capable of providing informed consent to participate in this study, - and affiliated with the French health insurance fund. Exclusion Criteria: - Refusal to participate, - Has a pacemaker or a neurostimulator, - Has an insulin pump, - Coagulation disorders, - Current thrombophlebitis, - Current pregnancy, - Burning sensation at the treatment area, - Current cancer, - Insensitivity to warm or to pain, - Current infection (tuberculosis, etc.), especially of the surgical site, - Current fever, - Bladder wound during cesarean, - Under guardianship or conservatorship, deprived freedom, or in the custody of correctional authorities, - Keloid scar from previous cesarean, - Previous tecar therapy, - Strong hypertension (systolic > 150 or diastolic > 100) or hypotension (systolic =90 and diastolic < 40 mm Hg), - Dermatologic lesion in the area to be treated (eczema, psoriasis, herpes zoster, etc.), - subumbilical midline incision. - Chronic inflammatory disease. - Under a guardianship or conservatorship, deprived of freedom, or in the custody of correctional authorities. |
Country | Name | City | State |
---|---|---|---|
France | CHU clermont-ferrand | Clermont-Ferrand | |
France | CH de Vichy | Vichy |
Lead Sponsor | Collaborator |
---|---|
University Hospital, Clermont-Ferrand |
France,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Analgesic efficacy of tecar therapy on postoperative scar pain and/or discomfort | To study the analgesic efficacy of tecar therapy on postoperative scar pain and/or discomfort after cesarean delivery. Pain will be evaluated by a visual analogic scale (VAS) at 3 months post partum, by a ruler scored from 0 for no pain and/or discomfort to 10 for the worst imaginable. | At 3 months after the cesarean delivery | |
Secondary | Pain and/or discomfort for cesarean scars at the end of all 3 sessions of tecar therapy | Pain and/or discomfort will be evaluated by a VAS, with a ruler scored from 0 for no pain to 10 for the worst imaginable. | Week 3 | |
Secondary | Pain and/or discomfort due to cesarean scar at 6 months post partum | Pain and/or discomfort will be evaluated by a VAS, with a ruler scored from 0 for no pain to 10 for the worst imaginable. | Month 6 | |
Secondary | Pain due to cesarean scar in the early postpartum period | Saint Antoine self-administered pain questionnaire, abridged version (QDSA, French adaptation of the McGill Pain questionnaire): at the end of the tecar therapy sessions | Week 3 | |
Secondary | Pain due to cesarean scar in the early postpartum period | Saint Antoine self-administered pain questionnaire, abridged version (QDSA, French adaptation of the McGill Pain questionnaire): at the end of the tecar therapy sessions | Month 3 | |
Secondary | Pain due to cesarean scar in the early postpartum period | Saint Antoine self-administered pain questionnaire, abridged version (QDSA, French adaptation of the McGill Pain questionnaire): at the end of the tecar therapy sessions | Month 6 | |
Secondary | Pain due to cesarean scar in the early postpartum period | Self-administered brief pain questionnaire (QCD, French version of the "Brief Pain Inventory") | Week 3 | |
Secondary | Pain due to cesarean scar in the early postpartum period | Self-administered brief pain questionnaire (QCD, French version of the "Brief Pain Inventory") | Month 3 | |
Secondary | Pain due to cesarean scar in the early postpartum period | Self-administered brief pain questionnaire (QCD, French version of the "Brief Pain Inventory") | Month 6 | |
Secondary | Research for neuropathic pain | Self-administered questionnaire to search for neuropathic pain [DN4] | Month 3 | |
Secondary | Research for neuropathic pain | Self-administered questionnaire to search for neuropathic pain [DN4] | Month 6 | |
Secondary | Interference with daily activities | Self-administered questionnaire "Multidimensional Pain Inventory" (MPI) | Week 3 | |
Secondary | Interference with daily activities | Self-administered questionnaire "Multidimensional Pain Inventory" (MPI) | Month 3 | |
Secondary | Interference with daily activities | Self-administered questionnaire "Multidimensional Pain Inventory" (MPI) | Month 6 | |
Secondary | Anxiety and depression | Self-administered questionnaire "Hospital Anxiety and Depression Scale" (HADS) | Month 3 | |
Secondary | Anxiety and depression | Self-administered questionnaire "Hospital Anxiety and Depression Scale" (HADS) | Month 6 | |
Secondary | Health-related quality of life | self-administered questionnaire WHOQOL-BRIEF [WHO questionnaire on Quality of Life] | Month 3 | |
Secondary | Health-related quality of life | self-administered questionnaire WHOQOL-BRIEF [WHO questionnaire on Quality of Life] | Month 6 | |
Secondary | Quality of sexual life | Self-administered questionnaire "Female Sexual Function Index" [FSFI] | Month 3 | |
Secondary | Quality of sexual life | Self-administered questionnaire "Female Sexual Function Index" [FSFI] | Month 6 | |
Secondary | Quality of skin healing | Vancouver Scale | Week 3 | |
Secondary | Consumption of analgesics or other co-treatments for analgesic purposes | consumption of analgesics and co-treatments collected prospectively during follow-up to allow the economic analysis | During the 3 months of follow-up. |
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT03772886 -
Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball
|
N/A | |
Completed |
NCT03631329 -
Predictability of Preoperative Carotid Artery Corrected Flow Time for Hypotension After Spinal Anesthesia in Patients Undergoing Cesarean Section
|
||
Completed |
NCT03244540 -
Regional Analgesia After Cesarean Section
|
Phase 4 | |
Active, not recruiting |
NCT03760718 -
Chloroprocaine Lavage to Improve Outcomes Related to Operative Cesarean Delivery
|
Early Phase 1 | |
Active, not recruiting |
NCT04965779 -
The Effect of Abdominal Binder Use on Postpartum Pain, Bleeding, and Breastfeeding Success in Cesarean Delivery Women
|
N/A | |
Terminated |
NCT01687972 -
INSORB Versus Subcuticular Sutures at Cesarean Section
|
Phase 1 | |
Withdrawn |
NCT01211431 -
Post-cesarean Pain Control Via Continuous Infusion of Ropivacain et Diclogenac Into the Wound Versus Intathecal Morphine
|
Phase 4 | |
Completed |
NCT00991627 -
Different Approaches to Maternal Hypotension During Cesarean Section
|
Phase 4 | |
Completed |
NCT00987701 -
Perineuraxial Anesthesia Fluid Management and Infant Neurobehaviors
|
N/A | |
Completed |
NCT01049477 -
The Effects of Music Therapy on Women's Anxiety Before and During Cesarean Delivery
|
N/A | |
Terminated |
NCT00524511 -
Comparison Study of Wound Closure at Time of Cesarean Delivery: Dermabond Glue Versus Surgical Staples
|
N/A | |
Terminated |
NCT00386477 -
Vaginal Cleansing at Cesarean Delivery to Reduce Infection: A Randomized, Controlled Trial
|
N/A | |
Completed |
NCT00375986 -
A Comparison of Manual vs. Spontaneous Removal of the Placenta at Cesarean Section
|
N/A | |
Completed |
NCT00517140 -
Vaginal Birth After Caesarean Section - Effect on Maternal Psychosocial Function
|
N/A | |
Terminated |
NCT05051150 -
Epinephrine Infusion for Prophylaxis Against Maternal Hypotension During Caesarean Section
|
Phase 4 | |
Terminated |
NCT03695172 -
Comparison of TAP, Anterior QL, or ESP Block for Elective Cesarean Section
|
Phase 4 | |
Recruiting |
NCT06247852 -
Persistent Pain After Cesarean Delivery - A Danish Multicenter Cohort Study
|
||
Completed |
NCT06012747 -
Pain After Cesarean Section - A Danish Multicenter Cohort Study.
|
||
Not yet recruiting |
NCT05187520 -
Naldebain for Control of Post-Cesarean Section Pain
|
Phase 2 | |
Not yet recruiting |
NCT04999670 -
Fascial Closure and Post-caesarean Pain
|
N/A |